|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | |||||||||||
| Current receivables – net (Note 4) | |||||||||||
| Nonrelated party | |||||||||||
| Related party | |||||||||||
| Total current receivables – net (Note 4) | |||||||||||
| Inventories, including deferred inventory costs (Note 5) | |||||||||||
| Current contract assets (Note 9) | |||||||||||
| All other current assets (Note 10) | |||||||||||
| Assets held for sale (Note 3) | |||||||||||
| Current assets | |||||||||||
| Property, plant, and equipment – net (Note 6) | |||||||||||
| Goodwill (Note 8) | |||||||||||
| Intangible assets – net (Note 8) | |||||||||||
| Contract and other deferred assets (Note 9) | |||||||||||
| Equity method investments (Note 11) | |||||||||||
| Deferred income taxes (Note 16) | |||||||||||
| All other assets (Note 10) | |||||||||||
| Total assets | |||||||||||
| Accounts payable and equipment project payables (Note 12) | |||||||||||
| Nonrelated party | |||||||||||
| Related party | |||||||||||
| Total accounts payable and equipment project payables (Note 12) | |||||||||||
| Contract liabilities and deferred income (Note 9) | |||||||||||
| All other current liabilities (Note 15) | |||||||||||
| Liabilities held for sale (Note 3) | |||||||||||
| Current liabilities | |||||||||||
| Long-term borrowings (Note 14) | |||||||||||
| Non-current compensation and benefits | |||||||||||
| All other liabilities (Note 15) | |||||||||||
| Total liabilities | |||||||||||
| Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 264,677,066 and 269,529,464 shares outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Retained earnings | |||||||||||
| Treasury common stock, 14,381,479 and 8,397,266 shares at cost as of September 30, 2026 and December 31, 2025, respectively | |||||||||||
| Net parent investment | |||||||||||
| Accumulated other comprehensive income (loss) – net attributable to GE Vernova (Note 17) | |||||||||||
| Total equity attributable to GE Vernova | |||||||||||
| Noncontrolling interests | |||||||||||
| Total equity | |||||||||||
| Total liabilities and equity |
Loading...